Your browser doesn't support javascript.
loading
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.
Hurt, Aeron C; Besselaar, Terry G; Daniels, Rod S; Ermetal, Burcu; Fry, Alicia; Gubareva, Larisa; Huang, Weijuan; Lackenby, Angie; Lee, Raphael T C; Lo, Janice; Maurer-Stroh, Sebastian; Nguyen, Ha T; Pereyaslov, Dmitriy; Rebelo-de-Andrade, Helena; Siqueira, Marilda M; Takashita, Emi; Tashiro, Masato; Tilmanis, Danielle; Wang, Dayan; Zhang, Wenqing; Meijer, Adam.
Afiliação
  • Hurt AC; WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia; Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address: aeron.
  • Besselaar TG; Global Influenza Programme, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
  • Daniels RS; The Francis Crick Institute, Worldwide Influenza Centre (WIC), Mill Hill Laboratory (formerly the WHO CC for Reference and Research on Influenza, MRC, National Institute for Medical Research), The Ridgeway, London NW7 1AA, UK.
  • Ermetal B; The Francis Crick Institute, Worldwide Influenza Centre (WIC), Mill Hill Laboratory (formerly the WHO CC for Reference and Research on Influenza, MRC, National Institute for Medical Research), The Ridgeway, London NW7 1AA, UK.
  • Fry A; WHO Collaborating Center for the Surveillance, Epidemiology and Control of Influenza, Centers for Diseases Control and Prevention, 1600 Clifton RD NE, MS-G16, Atlanta, GA, United States.
  • Gubareva L; WHO Collaborating Center for the Surveillance, Epidemiology and Control of Influenza, Centers for Diseases Control and Prevention, 1600 Clifton RD NE, MS-G16, Atlanta, GA, United States.
  • Huang W; WHO Collaborating Centre for Reference and Research on Influenza, National Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, China CDC, Beijing, China.
  • Lackenby A; National Infection Service, Public Health England, London NW9 5HT, UK.
  • Lee RT; Bioinformatics Institute, Agency for Science, Technology and Research, 30 Biopolis Street, #07-01, Matrix, Singapore 138671, Singapore.
  • Lo J; Public Health Laboratory Centre, 382 Nam Cheong Street, Hong Kong, China.
  • Maurer-Stroh S; Bioinformatics Institute, Agency for Science, Technology and Research, 30 Biopolis Street, #07-01, Matrix, Singapore 138671, Singapore; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore; National Public Health Laboratory, Ministry of Healt
  • Nguyen HT; WHO Collaborating Center for the Surveillance, Epidemiology and Control of Influenza, Centers for Diseases Control and Prevention, 1600 Clifton RD NE, MS-G16, Atlanta, GA, United States.
  • Pereyaslov D; Division of Communicable Diseases, Health Security, & Environment, World Health Organization Regional Office for Europe, UN City, Marmorvej 51, DK-2100 Copenhagen, Denmark.
  • Rebelo-de-Andrade H; Instituto Nacional de Saúde, Av. Padre Cruz, 1649-016 Lisboa, Portugal; Faculdade de Farmácia, Universidade de Lisboa, Av. Prof Gama Pinto, 1649-003 Lisboa, Portugal.
  • Siqueira MM; National Influenza Center, Laboratorio de Virus Respiratorios- Oswaldo Cruz Institute/FIOCRUZ-Rio de Janeiro, Brazil.
  • Takashita E; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama, Tokyo 208-0011, Japan.
  • Tashiro M; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama, Tokyo 208-0011, Japan.
  • Tilmanis D; WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
  • Wang D; WHO Collaborating Centre for Reference and Research on Influenza, National Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, China CDC, Beijing, China.
  • Zhang W; Global Influenza Programme, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
  • Meijer A; National Institute for Public Health and the Environment, PO Box 1, 3720 BA Bilthoven, The Netherlands.
Antiviral Res ; 132: 178-85, 2016 08.
Article em En | MEDLINE | ID: mdl-27265623
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Vírus da Influenza A / Proteínas Virais / Influenza Humana / Neuraminidase Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Vírus da Influenza A / Proteínas Virais / Influenza Humana / Neuraminidase Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article